Thymoglobulin: all 116 studies that test it
Page 2 of 2. Open to participants first (11), then studies with results posted, then the rest; newest registration first within each.
- Anti-T-Lymphocyte Globulin (ATG) in Renal Transplantation of Kidneys With a Non-Heart-Beating (NHB) DonorStatus unknownNCT00733733Phase 3
- Thymoglobulin in Calcineurin Inhibitor and Steroid Minimization ProtocolStatus unknownNCT00706680Phase 4
- Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Deceased Donor Renal TransplantationCompletedNCT00685061Phase 4
- Daclizumab Versus Thymoglobulin in Renal Transplant Recipients With High Immunological RiskCompletedNCT00682292Phase 3
- Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Living Donor Renal TransplantationCompletedNCT00681343Phase 4
- Allogeneic Transplantation for Pediatric Leukemias With Unrelated DonorsStatus unknownNCT00679536Phase 1/2
- Chronic Graft-versus-host Disease (cGvHD) Prophylaxis With or Without ATG Prior to Stem Cell Transplantation (SCT) From HLA-identical Siblings in Patients With Acute LeukemiaCompletedNCT00678275Phase 3
- Autologous Transplant Followed by Allogeneic Transplant for High Risk NeuroblastomaTerminatedNCT00670410Phase 1
- Acute Graft-Versus-Host Disease (aGvHD) Prophylaxis With ATG-Fresenius in Matched Unrelated Donor-Stem Cell Transplantation (MUD-SCT)CompletedNCT00655343Phase 3
- Intraoperative Versus Postoperative Thymoglobulin in Lung TransplantationWithdrawnNCT00592306Phase 3
- A Study of Thymoglobulin and Tacrolimus in Liver TransplantStatus unknownNCT00564538Phase 4
- A Phase I Study Of Thymoglobulin In Patients With Relapsed Or Refractory Multiple MyelomaCompletedNCT00545519Phase 1
- Thymoglobulin (ATG) Dose Finding StudyTerminatedNCT00409695Phase 1/2
- Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)CompletedNCT00402558Phase 1
- Single Dose Thymoglobulin for Induction in Adult Renal Allograft RecipientsTerminatedNCT00235781Not applicable
- Evaluation of Thymoglobulin Induction and Reduced Doses of Calcineurin Inhibitors on Liver Transplant RejectionCompletedNCT00117689Phase 2